Dunn, Christopher; Keam, Susan J. - In: PharmacoEconomics 24 (2006) 5, pp. 495-517
Letrozole (Femara(R)), an aromatase inhibitor that blocks estrogen synthesis by inhibiting the final step of the … postmenopausal women with hormone-responsive early-stage breast cancer have demonstrated that, as adjuvant therapy, letrozole has … tamoxifen therapy in these patients. In women with hormone-responsive advanced breast cancer, letrozole is superior to tamoxifen …